Compound Radar

Omada Health, Inc. (OMDA) Stock Analysis

Price $22.18
Market cap $1.36B
Next earnings Nov 5, 2026
Entry status Watch

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

45
45/100 Speculative
  • Financial Health 40
  • Profitability 90
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 45/100 — Speculative

Strongest Profitability 90/100
Softest Financial Health 40/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Omada Health, Inc. (OMDA) is a Health Information Services company in the Healthcare sector. Compound Radar rates Omada Health, Inc. 45/100 (Speculative) due to high business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Elevated

Financial highlights

Valuation

  • P/E 33.1
  • Forward P/E 39.88
  • EV/Revenue 3.78

Profitability

  • Revenue Growth 43.1%
  • Gross Margin 68.2%
  • Operating Margin 4.0%
  • Net Margin 1.4%
  • ROE 1.8%

Financial strength

  • Cash $221.71M
  • Debt $0.00
  • Net Cash $221.71M
  • Free Cash Flow $12.42M
  • Current Ratio 3.91

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Omada Health, Inc. (OMDA).

View Methodology & FAQ →